Categories:

• Agriculture and Forestry
• Automotive
• Biotechnology and Pharmaceuticals
• Chemicals
• Construction and Maintenance
• Consumer Goods and Services
• Electronics and Electrical
• Energy and Environment
• Food and Related Products
• Industrial Goods and Services
• Information Technology
• Materials
• Real Estate
• Telecommunications
• Textiles and Nonwovens
• Transportation and Logistics

Popular Tags:

• player
• mp4
• mp4 player
• screen
• player screen
• screen mp4
• 4gb
• player 4gb
• 4gb mp4
• card
• slot
• player card
• 18inch
• inch
• 15inch
• inch mp4
• inch player
• flash
• style
• builtin

Home › Sub-Optimal 39% Hep C Cure Rate Keeps Merck In Gilead's Rear View

 

Sub-Optimal 39% Hep C Cure Rate Keeps Merck In Gilead's Rear View

2014-11-13 14:42:27| Biotech - Topix.net

Until Merck's product can deliver an optimal cure rate at a cheaper price, it poses no threat to Gilead's Harvoni. Merck's attempt to compete with Gilead in finding a cure for hepatitis C has fallen short .

Tags: view rate rear cure

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»

05.11 Registration Now Open for RadTech 2025 05.11 Atlantic Tropical Weather Outlook 05.11 Eastern North Pacific Tropical Weather Outlook 05.11 Tropical Storm Rafael Graphics 05.11 Tropical Storm Rafael Public Advisory Number 7A 05.11 Summary for Tropical Storm Rafael (AT3/AL182024) 05.11 Vodafone-Three merger could get green light, watchdog says 05.11 Altice USA residential video RGUs down 77,000 in 3Q 2024 More »